Skip to main content
. Author manuscript; available in PMC: 2019 Dec 21.
Published in final edited form as: Cancer Gene Ther. 2019 Jun 20;27(6):438–447. doi: 10.1038/s41417-019-0112-z

Figure 3. Immunohistochemical assessment of the tumor from patient #003 treated with the fowlpox vector expressing GM-CSF following cystectomy:

Figure 3.

Patient #003 received a weekly intravesical dose of 7.02 × 107 PFU rFP-GM-CSF with the fourth dose instilled 2 days prior to cystectomy. A and B H&E stain, C and D CD3, E and F CD4, G and H CD8, I and J CD45RO, K and L factor XIIIa (Dendritic cells), M and N CD30, O and P CD1a, Q and R Immunostaining negative control.